🇺🇸 FDA
Patent

US 8883771

Bivalent inhibitors of IAP proteins and therapeutic methods using the same

granted A61KA61K31/407A61K31/496

Quick answer

US patent 8883771 (Bivalent inhibitors of IAP proteins and therapeutic methods using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/407, A61K31/496, A61K45/06, A61P